Scroll to Content

The Canadian Consortium for the Investigation of Cannabinoids is a federally registered Canadian nonprofit organization that promotes evidence-based research and education concerning the endocannabinoid system and therapeutic applications of endocannabinoid and cannabinoid agents. This is done via educating, facilitating, creating, and advancing the basic and clinical research on the therapeutic applications of cannabinoids.

The CCIC began as a national interdisciplinary research consortium in 2000, with researchers from basic and clinical sciences and other health care practitioners. The purpose of the CCIC is to advance our understanding of the role of cannabinoids in health and disease through research and education. The CCIC has consulted for Senate committee reports, regulatory guidelines for medical marijuana and CCIC members have conducted and published research on cannabinoids with an aim of providing a credible source of information on cannabinoids for the public and health care practitioners.

For more information, research, policies, and annual reports check out the the Canadian Consortium for the Investigation of Cannabinoids (CCIC)’s website here:

Canadian Cannabionoids CCIC logo-white

Also this informative Video by Leanne Chan (2011):

Visualization of the endocannabinoid signaling system

And here are some slides from the CCIC’s online Slide Bank:

Cannabis-MedHistory-Slide08 CCIC Clinical Potential-Slide12 CCIC-HumanResearch-Slide25 Cannabinoid-Synergism-Slide56 HealthCan-MMAR-2002-2009

 More info at

Written by: